• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外循环期间,比伐芦定可作为“肝素过敏”的替代药物。

Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass.

作者信息

Parissis Haralabos

机构信息

Cardiothoracic Dept, Royal Victoria Hospital, Grosvernor Rd, Belfast, BT12 6BA, Northern Ireland.

出版信息

J Cardiothorac Surg. 2011 Apr 8;6:44. doi: 10.1186/1749-8090-6-44.

DOI:10.1186/1749-8090-6-44
PMID:21477293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3079612/
Abstract

A treatment strategy of a difficult and unusual problem is presented. We are reporting a case of a patient who had a documented allergy to heparin and required Cardiac surgery for an ASD closure. The anticoagulation regime used during cardiopulmonary bypass was lepirudin based. This report indicates that r-hirudin provides effective anticoagulation, however unless ECT is monitoring, post operative hemorrhage is encountered. Therefore this case is unique not only because of its rarity but also by the fact that it presents the caveats encountered when ECT is not available.

摘要

本文提出了一种针对疑难罕见问题的治疗策略。我们报告了一例有肝素过敏记录且因房间隔缺损封堵术需要进行心脏手术的患者。体外循环期间使用的抗凝方案是以重组水蛭素为基础的。本报告表明重组水蛭素可提供有效的抗凝作用,然而,除非进行活化凝血时间(ACT)监测,否则会出现术后出血。因此,该病例不仅因其罕见性而独特,还因其呈现了在无法进行ACT监测时所遇到的注意事项。

相似文献

1
Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass.在体外循环期间,比伐芦定可作为“肝素过敏”的替代药物。
J Cardiothorac Surg. 2011 Apr 8;6:44. doi: 10.1186/1749-8090-6-44.
2
Anticoagulation for patients with heparin-induced thrombocytopenia using recombinant hirudin during cardiopulmonary bypass.在体外循环期间使用重组水蛭素对肝素诱导的血小板减少症患者进行抗凝治疗。
J Clin Anesth. 2002 Sep;14(6):452-5. doi: 10.1016/s0952-8180(02)00386-0.
3
Management of anticoagulation during cardiopulmonary bypass in a patient with allergy to heparin and heparin-like compounds: a case-report.对肝素和类肝素化合物过敏患者在体外循环期间的抗凝管理:一例报告
Blood Coagul Fibrinolysis. 2014 Dec;25(8):900-3. doi: 10.1097/MBC.0000000000000152.
4
Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.重组水蛭素抗凝用于肝素诱导的血小板减少症患者的主动脉瓣置换术
Can J Anaesth. 2000 Mar;47(3):255-60. doi: 10.1007/BF03018923.
5
[Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].[使用全血中的蛇毒凝血时间监测肝素诱导的血小板减少症患者体外循环期间重组水蛭素治疗情况]
Ann Biol Clin (Paris). 2005 Mar-Apr;63(2):201-8.
6
Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.在肝素诱导的血小板减少症及体外循环中使用依卡凝血时间(ECT)联合比伐卢定治疗。
J Extra Corpor Technol. 2001 May;33(2):117-25.
7
Bidirectional glenn shunt surgery using lepirudin anticoagulation in an infant with heparin-induced thrombocytopenia with thrombosis.
Anesth Analg. 2005 Jul;101(1):74-6, table of contents. doi: 10.1213/01.ANE.0000153019.15297.0B.
8
Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.重组水蛭素用于体外循环抗凝:一项随机、前瞻性且以肝素为对照的初步研究。
Thorac Cardiovasc Surg. 2007 Jun;55(4):233-8. doi: 10.1055/s-2006-955956.
9
Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.体外循环期间重组水蛭素抗凝监测——全血蛇静脉酶凝血时间评估
Thromb Haemost. 1997 May;77(5):920-5.
10
Monitoring of hirudin therapy with the Thrombelastograph.使用血栓弹力图监测水蛭素治疗。
J Clin Anesth. 2002 Sep;14(6):456-8. doi: 10.1016/s0952-8180(02)00398-7.

引用本文的文献

1
Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy.比伐卢定在肝素过敏患者体外循环中的应用。
J Cardiothorac Surg. 2023 Sep 11;18(1):258. doi: 10.1186/s13019-023-02359-2.
2
Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.植物药在 COVID-19 住院患者凝血功能障碍管理中的潜在临床应用。
Phytother Res. 2022 May;36(5):1884-1913. doi: 10.1002/ptr.7408. Epub 2022 Feb 11.

本文引用的文献

1
Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy.在一名肝素过敏患者中成功使用比伐卢定进行体外循环。
Perfusion. 2007 Jan;22(1):67-9. doi: 10.1177/0267659106076004.
2
Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.重组水蛭素用于体外循环抗凝:一项随机、前瞻性且以肝素为对照的初步研究。
Thorac Cardiovasc Surg. 2007 Jun;55(4):233-8. doi: 10.1055/s-2006-955956.
3
Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.接受心脏手术的肝素诱导的血小板减少症患者的替代抗凝管理策略。
J Cardiothorac Vasc Anesth. 2007 Feb;21(1):113-26. doi: 10.1053/j.jvca.2006.08.011. Epub 2006 Oct 24.
4
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.在接受体外循环心脏手术的患者中,比伐芦定与肝素加鱼精蛋白逆转剂的比较:EVOLUTION-ON研究。
J Thorac Cardiovasc Surg. 2006 Mar;131(3):533-9. doi: 10.1016/j.jtcvs.2005.09.057.
5
Anticoagulation management and cardiac surgery in patients with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患者的抗凝管理与心脏手术
Semin Thorac Cardiovasc Surg. 2005 Spring;17(1):85-96. doi: 10.1053/j.semtcvs.2004.12.008.
6
Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.水蛭素:一种用于抗凝治疗的双价直接凝血酶抑制剂。
Expert Rev Cardiovasc Ther. 2004 May;2(3):339-57. doi: 10.1586/14779072.2.3.339.
7
Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患者中与重组水蛭素相关的过敏反应和类过敏反应。
Circulation. 2003 Oct 28;108(17):2062-5. doi: 10.1161/01.CIR.0000096056.37269.14. Epub 2003 Oct 20.
8
Heparin-induced thrombocytopenia: pathogenesis and management.肝素诱导的血小板减少症:发病机制与管理
Br J Haematol. 2003 May;121(4):535-55. doi: 10.1046/j.1365-2141.2003.04334.x.
9
Recombinant hirudin in clinical practice: focus on lepirudin.
Circulation. 2001 Mar 13;103(10):1479-84. doi: 10.1161/01.cir.103.10.1479.
10
Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients.重组水蛭素作为肝素诱导的II型血小板减少症患者体外循环期间抗凝的替代药物:57例患者的1年经验
J Cardiothorac Vasc Anesth. 2000 Jun;14(3):243-8.